Clinical trial
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol…
NCT00249119 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00249119 |
|---|---|
| Title | A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia |
| Official title | Risperidone in the Treatment of Chronic Schizophrenic Patients: an International Multicentre Double-blind Parallel-group Comparative Study Versus Haloperidol. |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia, Psychotic Disorder |
| Intervention type | Drug |
| Interventions | risperidone |
| Enrollment | 1,579 |
| Completion | Dec 1, 1991 |
| First posted | Nov 7, 2005 |
| Last update posted | Feb 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: